Lipitor patent
Pfizer’s chief executive Jeffrey B Kindler moved to reassure investors the company was still in good shape. The patent was Lipitor patent challenged jointly by generic companies Laboratorios Cinfa S. , Kern Pharma S. , Laboratorios Alter S. Court of Appeals for the Federal Circuit in Washington upheld a lower court’s finding that a planned generic drug by Ranbaxy Laboratories Ltd. However, the sales share of statins will decline from $21 billion in 2006 to $7. 8 billion in 2016 owing to generic erosion and greater use of fixed-dose combination therapies that offer lipitor patent dual modes of action and/or modulate high-density lipoprotein (HDL) in addition to low- density lipoprotein (LDL) cholesterol. About Links Medical Products Inc. The $60 billion Pharmacia merger propelled Pfizer to the top but was a mixed blessing. Analyst Timothy Anderson wrote that Wall Street is divided on how the lipitor patent u. Indications for the drug were extended last month when the agency issued an approvable letter for Pristiq to treat hot flashes and night sweats associated with menopause. We think lipitor patent etc-2f6 could be Pfizer’s ticket to continued robust earnings growth after its Lipitor patents expire in 2006, S&P stated. This initial action, which is how the Office raises its issues with the patentee, will now be followed by the company’s response, in which Pfizer will address those issues raised by the examiner. In a Food & Drug Packaging article earlier this year, Tom McPhillips, vice president of U. Invega is marketed by Janssen (a division of Johnson & Johnson) and became available in January of this year. Pfizer had been counting on torcetrapib to make up for several patent expirations, including one on cholesterol-lowering Lipitor, Pfizer’s top-selling product with $12 billion in annual sales. Deutsche Bank large cap pharma analyst Barbara Ryan speculated that layoffs could top 10,000 in the near future-about 10% of its workforce. The Patent Office had conducted a re-examination of the ‘893 patent in response to a request by a law firm that represented Lipitor patent the generic company Ranbaxy Laboratories Limited. However, according to the latest visiongain report specifically focussed on the drug company, the next five years may not be as positive. Roche is developing a similar compound-slated for approval in 2009-as is Merck. Cinfa, Kern, Alter and Belmac can seek to appeal the decision to the Supreme Court of Spain. NEW YORK — Pfizer Inc announced today that the lipitor patent u. CEO Hank McKinnell, speaking at the World Economic Forum in June, said the firm is seeing double-digit growth throughout Asian markets. Pfizer said the decision upholding the exclusivity of the patent covering atorvastatin until November 2011 was an important victory for scientists. The five year period to 2011 could see $20 billion of additional revenues generated by the generics companies, significantly enhancing their growth prospects. As well as lipitor patent major distributors nationwide. A two-week trial in the case ended last month and a federal lipitor patent judge in Delaware is expected to issue his decision in the next six to 12 months. We believed that the study was coming along as expected, and this new information was Lipitor patent totally unexpected and disappointing, given the potential benefits of this drug. Only on Friday, the group had issued an upbeat trading statement, including some reassurance that the Torcetrapib trials were on track.